European Cancer Organisation's Response to EU Pharmaceutical Strategy Roadmap Consultation

The European Cancer Organisation welcomed the commitment to producing a new EU Pharmaceutical Strategy, and the accompanying commitment to public consultation on its content.

The European Cancer Organisation's response articulates seven (7) key recommendations:

1. Ensure the new EU Pharmaceutical Strategy is ambitious and comprehensive

2. Remodel the incentive structures further towards value and outcomes, and support innovation in all areas of treatment and care

3. Resolve the current political impasse on the HTA cooperation proposal

4. Leverage data and new tools in a more coherent and powerful way

5. Reduce bureaucracy in the clinical trial landscape

6. Urgently address the medicines shortages crisis

7. Work with medical and healthcare professional societies and patient associations as equal partners in creating the best possible changes
   
   

Read the Response here.